559396 Sigma-AldrichSB 220025
A cell-permeable, potent, reversible, ATP-competitive, and specific inhibitor of human p38 MAP Kinase (IC₅₀ = 60 nM).
More>> A cell-permeable, potent, reversible, ATP-competitive, and specific inhibitor of human p38 MAP Kinase (IC₅₀ = 60 nM). Less<<Synonyms: 5-(2-Amino-4-pyrimidinyl)-4-(4-fluorophenyl)-1-(4-piperidinlyl)imidazole, p38 MAP Kinase Inhibitor XIV
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
165806-53-1 | C₁₈H₁₉FN₆ |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
559396-500UG |
|
Plastic ampoule | 500 μg |
|
— |
References | |
---|---|
References | Jackson, J.R., et al. 1998. J. Pharmacol. Exp. Ther. 284, 687. Wang, Z., et al. 1998. Structure 6, 1117. |
Product Information | |
---|---|
CAS number | 165806-53-1 |
Form | White to pale yellow solid |
Hill Formula | C₁₈H₁₉FN₆ |
Chemical formula | C₁₈H₁₉FN₆ |
Hygroscopic | Hygroscopic |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | P38MAPK |
Primary Target IC<sub>50</sub> | 60 nM |
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
559396-500UG | 07790788051549 |
Documentation
Required Licenses
Title |
---|
PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
SB 220025 SDS
Title |
---|
SB 220025 Certificates of Analysis
Title | Lot Number |
---|---|
559396 |
References
Reference overview |
---|
Jackson, J.R., et al. 1998. J. Pharmacol. Exp. Ther. 284, 687. Wang, Z., et al. 1998. Structure 6, 1117. |